60 Degrees Pharmaceuticals (SXTPW) Income from Non-Controlling Interests (2022 - 2025)
Historic Income from Non-Controlling Interests for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to -$712.0.
- 60 Degrees Pharmaceuticals' Income from Non-Controlling Interests rose 14.03% to -$712.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6555.0, marking a year-over-year increase of 8301.9%. This contributed to the annual value of -$8556.0 for FY2024, which is 8221.13% up from last year.
- According to the latest figures from Q3 2025, 60 Degrees Pharmaceuticals' Income from Non-Controlling Interests is -$712.0, which was up 14.03% from -$1204.0 recorded in Q2 2025.
- In the past 5 years, 60 Degrees Pharmaceuticals' Income from Non-Controlling Interests ranged from a high of $5390.0 in Q4 2022 and a low of -$33933.0 during Q4 2023
- In the last 4 years, 60 Degrees Pharmaceuticals' Income from Non-Controlling Interests had a median value of -$1978.0 in 2024 and averaged -$4301.5.
- In the last 5 years, 60 Degrees Pharmaceuticals' Income from Non-Controlling Interests plummeted by 72955.47% in 2023 and then skyrocketed by 9261.6% in 2024.
- 60 Degrees Pharmaceuticals' Income from Non-Controlling Interests (Quarter) stood at $5390.0 in 2022, then tumbled by 729.55% to -$33933.0 in 2023, then surged by 88.55% to -$3887.0 in 2024, then skyrocketed by 81.68% to -$712.0 in 2025.
- Its Income from Non-Controlling Interests was -$712.0 in Q3 2025, compared to -$1204.0 in Q2 2025 and -$752.0 in Q1 2025.